Literature DB >> 17081796

Deep brain stimulation of globus pallidus internus for dystonia.

John Y K Lee1, Milind Deogaonkar, Ali Rezai.   

Abstract

Neuromodulation is the functional modification of neural structures through the use of electrical stimulation. Its most clinically applicable use is deep brain stimulation (DBS) of basal ganglia structures in Parkinson's disease (PD) and essential tremor (ET). More recently, it has been used as a means of treating dystonic movement disorders. The main target of DBS for dystonia is the posteroventral globus pallidus internus (GPi), although the thalamus has been used as an alternate target in a minority of cases. In comparison to the effects seen in PD, the improvement in dystonic postures appear to differ in several ways--delay of clinical benefit, higher voltage requirements, and varied stimulator settings. In this review, the authors discuss the clinical characteristics, pathophysiology, microelectrode recording (MER) signatures, optimal surgical targets, programming parameters and outcomes in dystonia.

Entities:  

Mesh:

Year:  2006        PMID: 17081796     DOI: 10.1016/j.parkreldis.2006.07.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  9 in total

1.  Serial (1)H-MRS of thalamus during deep brain stimulation of bilateral globus pallidus internus for primary generalized dystonia.

Authors:  Mikhail F Chernov; Taku Ochiai; Takaomi Taira; Yuko Ono; Ryoichi Nakamura; Yoshihiro Muragaki; Hiroshi Iseki; Tomokatsu Hori; Kintomo Takakura
Journal:  Neuroradiology       Date:  2008-09-30       Impact factor: 2.804

Review 2.  Practical considerations and nuances in anesthesia for patients undergoing deep brain stimulation implantation surgery.

Authors:  Danielle Teresa Scharpf; Mayur Sharma; Milind Deogaonkar; Ali Rezai; Sergio D Bergese
Journal:  Korean J Anesthesiol       Date:  2015-07-28

3.  An evaluation of rating scales utilized for deep brain stimulation for dystonia.

Authors:  Frandy Susatia; Irene A Malaty; Kelly D Foote; Samuel S Wu; Pamela R Zeilman; Mitushi Mishra; Ramon L Rodriguez; Ihtsham ul Haq; Charles E Jacobson; Anqi Sun; Michael S Okun
Journal:  J Neurol       Date:  2009-07-29       Impact factor: 4.849

4.  Comonitoring of adenosine and dopamine using the Wireless Instantaneous Neurotransmitter Concentration System: proof of principle.

Authors:  Young-Min Shon; Su-Youne Chang; Susannah J Tye; Christopher J Kimble; Kevin E Bennet; Charles D Blaha; Kendall H Lee
Journal:  J Neurosurg       Date:  2010-03       Impact factor: 5.115

5.  Efficacy of zolpidem for dystonia: a study among different subtypes.

Authors:  Yoshimichi Miyazaki; Wataru Sako; Kotaro Asanuma; Yuishin Izumi; Tetsuro Miki; Ryuji Kaji
Journal:  Front Neurol       Date:  2012-04-17       Impact factor: 4.003

6.  Ultra-high field magnetic resonance imaging of the basal ganglia and related structures.

Authors:  Birgit R Plantinga; Yasin Temel; Alard Roebroeck; Kâmil Uludağ; Dimo Ivanov; Mark L Kuijf; Bart M Ter Haar Romenij
Journal:  Front Hum Neurosci       Date:  2014-11-05       Impact factor: 3.169

7.  Pregnancy and Delivery in a Generalized Dystonia Patient Treated with Internal Globus Pallidal Deep Brain Stimulation: a Case Report.

Authors:  Hye Ran Park; Jae Meen Lee; Hyeyoung Park; Chae Won Shin; Han Joon Kim; Hee Pyoung Park; Dong Gyu Kim; Beom Seok Jeon; Sun Ha Paek
Journal:  J Korean Med Sci       Date:  2017-01       Impact factor: 2.153

Review 8.  The Symptomatic Treatment of Acquired Dystonia: A Systematic Review.

Authors:  Corina N A M van den Heuvel; Marina A J Tijssen; Bart P C van de Warrenburg; Cathérine C S Delnooz
Journal:  Mov Disord Clin Pract       Date:  2016-08-03

9.  Long-Term Clinical Outcome of Internal Globus Pallidus Deep Brain Stimulation for Dystonia.

Authors:  Hye Ran Park; Jae Meen Lee; Gwanhee Ehm; Hui-Jun Yang; In Ho Song; Yong Hoon Lim; Mi-Ryoung Kim; Keyoung Ran Kim; Woong-Woo Lee; Young Eun Kim; Jae Ha Hwang; Chae Won Shin; Hyeyoung Park; Jin Wook Kim; Han-Joon Kim; Cheolyoung Kim; Dong Gyu Kim; Beom Seok Jeon; Sun Ha Paek
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.